Searched for
JAPANESE PHARMA
Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- After 50 hearings, court reserves judgement in Daiichi-Fortis caseThe Delhi High Court has reserved its judgment in a significant arbitration case. Japanese drug maker Daiichi Sankyo is seeking to enforce ...
- IHH-Daiichi legal battle nears verdict on September 10A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...
- GIFT Nifty jumps 110 points on Iran-US peace talk hopes; Nifty seen reclaiming 24K on MondayGIFT Nifty surged 110 points on hopes of renewed Iran-US peace talks, boosting sentiment after weak markets. Positive global cues could hel...
- Global Markets | Japan's Nikkei climbs as AI optimism outweighs Mideast concernsJapanese stocks surged Monday, nearing a historic peak, fueled by booming AI sector enthusiasm that overshadowed Middle East tensions. Majo...
- The yen connection: 4 Indian pharma stocks which benefit from the strength of Japanese yen with an upside potential of up to 15%Every event in the currency market has a twin impact, while some lose but there are others which also gain. But given the mayhem on the str...
- Japan shares slip for third day; all eyes on US stimulus debateThe Nikkei share average lost 0.30% to close at 26,467.08. The broader Topix shed 0.11% to 1,758.81, after touching its lowest since Nov. 2...
- Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...
- Deal with Ranbaxy: Should Daiichi Sankyo have followed the Nemawashi way?A core value of Japanese business is trust. And this is where Daiichi Sankyo’s Ranbaxy problem may start to hurt India-Japan ties.
- Claris transfers two businesses to Japan JV for Rs 1,050 crClaris will continue to hold a 20 per cent stake in the JV, while Otsuka and Mitsui will hold 60 and 20 per cent in it, respectively, a com...
- Japanese pharma cos keen on tie-ups with Indian companiesA delegation of pharmaceutical firms from Japan's Toyama prefecture today indicated that Japanese companies are keen to collaborate with In...
- India likely to press for more access to Japanese pharma marketThe CEPA between India and Japan came into effect from August 1 2011. Both the sides expects that it would boost bilateral trade.
- Japan may open up to Indian genericsJapan has veered round to considering India’s demand to open up its over $100-billion pharmaceutical market to Indian generic, or off-paten...
- Ranbaxy to shift admin to MumbaiRanbaxy Laboratories, India’s largest pharma company by sales, is looking to shift its marketing and administrative teams from its Gurgaon ...
- Japan's Daiichi to set up manufacturing, research unitThe $8-billion Daiichi Sankyo Company, Japan’s second-largest pharma company, is in the process of setting up a full-fledged manufacturing ...
- Lupin makes a leap into Japanese pharma marketLupin’s acquisition in Japan gives it a foothold in a large pharmaceutical market with relatively low generic penetration. Japan is the wor...
- Zydus scouts for partners in Land of Rising SunThe company is in talks with 2-3 pharma companies and has earmarked an investment of about $25 million for its expansion plans in Japan.
Load More
